T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.81B |
| 2 |
XYZ
Block Inc
XYZ
|
+$1.46B |
| 3 |
Accenture
ACN
|
+$1.23B |
| 4 |
Gilead Sciences
GILD
|
+$1.15B |
| 5 |
Valero Energy
VLO
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.61B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.06B |
| 3 |
Tesla
TSLA
|
+$1.81B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.72B |
| 5 |
Amazon
AMZN
|
+$1.59B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.44% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 12.3% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
ITT
ITT
$19.4B
| $7.72M | ﹤0.01% |
59,736
+5,301
| +10% | +$755K |
|
1152
Parsons
PSN
$5.16B
| $7.65M | ﹤0.01% |
129,177
+101,387
| +365% | +$7.34M |
|
1153
Caesars Entertainment
CZR
$6.04B
| $7.58M | ﹤0.01% |
303,294
+812
| +0.3% | +$26.4K |
|
1154
Rivian
RIVN
$22.9B
| $7.5M | ﹤0.01% |
602,668
+54,070
| +10% | +$680K |
|
1155
TD Synnex
SNX
$20.4B
| $7.46M | ﹤0.01% |
71,757
-5,298
| -7% | -$708K |
|
1156
Crown Holdings
CCK
$13.1B
| $7.45M | ﹤0.01% |
83,452
+6,100
| +8% | +$532K |
|
1157
Oric Pharmaceuticals
ORIC
$1.42B
| $7.44M | ﹤0.01% |
1,332,860
+37,835
| +3% | +$331K |
|
1158
Corcept Therapeutics
CORT
$12.1B
| $7.41M | ﹤0.01% |
64,892
+10,139
| +19% | +$617K |
|
1159
WisdomTree
WT
$3.44B
| $7.36M | ﹤0.01% |
825,202
-91,455
| -10% | -$852K |
|
1160
EyePoint Inc
EYPT
$1.17B
| $7.34M | ﹤0.01% |
1,354,014
-790,733
| -37% | -$5.53M |
|
1161
UGI
UGI
$7.53B
| $7.34M | ﹤0.01% |
221,823
+14,572
| +7% | +$462K |
|
1162
Essential Utilities
WTRG
$11.3B
| $7.33M | ﹤0.01% |
185,445
+12,281
| +7% | +$451K |
|
1163
Doximity
DOCS
$4.74B
| $7.33M | ﹤0.01% |
126,217
-54,526
| -30% | -$3.44M |
|
1164
Kaspi.kz JSC
KSPI
$18.9B
| $7.28M | ﹤0.01% |
78,357
+6,297
| +9% | +$617K |
|
1165
Allison Transmission
ALSN
$10.2B
| $7.27M | ﹤0.01% |
75,960
+20,727
| +38% | +$2.2M |
|
1166
Ally Financial
ALLY
$13.6B
| $7.25M | ﹤0.01% |
198,645
+4,653
| +2% | +$171K |
|
1167
RH
RH
$3.41B
| $7.24M | ﹤0.01% |
30,883
-476,430
| -94% | -$165M |
|
1168
Bio-Rad Laboratories Class A
BIO
$9.68B
| $7.18M | ﹤0.01% |
29,475
+331
| +1% | +$99.6K |
|
1169
Flex
FLEX
$45.9B
| $7.18M | ﹤0.01% |
216,956
+39,367
| +22% | +$1.54M |
|
1170
SouthState Bank Corp
SSB
$10.8B
| $7.08M | ﹤0.01% |
76,252
+20,150
| +36% | +$1.98M |
|
1171
Omega Healthcare
OHI
$13.9B
| $7.08M | ﹤0.01% |
185,744
+19,013
| +11% | +$707K |
|
|
SGI
1172
Somnigroup International
SGI
$13.5B
| $7.07M | ﹤0.01% |
118,056
+14,320
| +14% | +$867K |
|
|
CNH
1173
CNH Industrial
CNH
$17.3B
| $7M | ﹤0.01% |
570,363
+58,325
| +11% | +$731K |
|
1174
First Horizon
FHN
$12.3B
| $6.99M | ﹤0.01% |
359,685
+37,473
| +12% | +$771K |
|
1175
Freshpet
FRPT
$3.48B
| $6.96M | ﹤0.01% |
83,615
-4,532
| -5% | -$555K |
|
Similar funds
T. Rowe Price Associates's Q1 2025 Portfolio in Review
As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
- T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
- T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
- T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
- T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
- T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.
Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.